EGFR gene amplification has been associated to several human malignancies, including oesophageal cancer, glioblastoma, anal cancers, malignancies of the epithelium of the head and neck, breast cancers, and lung cancers, particularly non-small-cell lung cancers (NSCLCs).3–6. This evidence concerns the gene EGFR and non-small cell lung carcinoma.